Good news from the USPTO, especially for small businesses working on COVID-19-treating inventions!
On May 8, the United States Patent and Trademark Office issued this press release regarding a pilot program to provide prioritized examination to micro and small entities, without the usual prioritized examination fees, for patent applications directed toward products or processes that are subject to FDA approval for preventing or treating COVID-19, to encourage cutting-edge innovation and help potentially live-saving inventions get to market and available to the public more quickly.